A clinical case of atopic dermatitis with a rapid positive effect from the use of a genetically engineered biological drug in a teenager
Introduction. The instructions for the drug dupilumab indicate that the administration of a single loading dose on the first day leads to the rapid achievement of clinically effective concentrations within 2 weeks, which we saw in the example of our patient and her real clinical response to the firs...
Saved in:
Main Authors: | E. V. Churyukina, E. A. Portnyaga |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Association of Paediatric Allergists and Immunologists of Russia (APAIR)
2024-05-01
|
Series: | Аллергология и Иммунология в Педиатрии |
Subjects: | |
Online Access: | https://adair.elpub.ru/jour/article/view/128 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Experience with dupilumab in patients with atopic dermatitis
by: E. A. Glukhova, et al.
Published: (2023-07-01) -
New Era in Atopic Dermatitis Treatment: Results of Long-Term Dupilumab Administration
by: Nikolay N. Murashkin, et al.
Published: (2021-11-01) -
Efficacy of dupilumab plus topical corticosteroids in children with atopic dermatitis: A meta‐analysis of randomized controlled trials
by: Li Wang, et al.
Published: (2024-01-01) -
The application of the biological treatment in atopic dermatitis: focus on dupilumab
by: Yu. S. Smolkin, et al.
Published: (2023-03-01) -
The Effect of Dupilumab on Growth Parameters in Pediatric Atopic Dermatitis Patients
by: Vincenzo Piccolo, et al.
Published: (2025-07-01)